Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 |
filingDate |
2022-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2022-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-114591429-B |
titleOfInvention |
Antibodies that bind beta-amyloid and uses thereof |
abstract |
The present application provides anti-beta-amyloid antibodies and uses thereof. The anti-β-amyloid antibody of the present application can specifically bind to primate β-amyloid, and preferably has a high-affinity effect on human β-amyloid. The antibodies of the present application can be used to detect beta-amyloid and/or to diagnose Alzheimer's disease. |
priorityDate |
2022-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |